Northstar Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
PolyBox raises £700k in funding to automate data reporting in real-time for marketing teams
PolyBox provides a real-time platform that brings market data together for marketing teams and turns it into reports, forecasts and models. Built by marketers for marketers, the platform is designed to be used without in-depth technological knowledge.
Gnosis Health raises £1.1m led by SFC Capital to build digital healthcare assistant for Parkinson's disease
Gnosis Health is building MAXine, a digital healthcare assistant for Parkinson’s disease. MAXine uses data from wearables, patient reported outcomes and behavioural patterns to support patient self-management and communication with care teams.
H2CHP raises £1.5m from Northstar Ventures and Blackfinch Ventures for fuel-flexible generators built for changing power demands
H2CHP develops distributed electric generators that can run on hydrogen, ammonia, biofuels and e-fuels. The technology is designed for applications including data centres, ports, construction sites, backup power systems and microgrids, while reducing reliance on permanent magnets and rare-earth materials.
NunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale
NunaBio develops an enzymatic DNA synthesis platform that manufactures high fidelity synthetic DNA at scale. The platform enables customers in sectors such as medicine, biotechnology and diagnostics to access complex DNA formats that are difficult to produce using traditional methods.
Northstar Ventures lead £1.6m funding round into AI-powered customer feedback analysis provider Wordnerds
Wordnerds uses AI and behavioural science to analyse large volumes of customer feedback, turning unstructured data into real-time insights that organisations can act on quickly.
Newcells raises further £1.2m funding for laboratory models that speed up drug development
Newcells develops advanced human tissue models that replace animal testing in drug development, helping pharmaceutical companies predict safety and efficacy more accurately before clinical trials.
More venture news
- 19 Aug 2026
EcoNomad SolutionsEcoNomad Solutions raises £400k in funding led by British Design Fund for small-farm waste-to-energy systems
EquityAgriculture - 19 Aug 2026
Singular PhotonicsSingular Photonics raises £1.6m in funding led by ACF Investors to build single-photon image sensors that analyse light as it lands
EquityDeep Tech - 5 Aug 2026
VisaDocVisaDoc secures a six-figure investment from Mercia to automate the visa process for business travellers
EquityLegal
